Correction to: Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells

Correction to: Cell Mol Neurobiol (2016) 36:829–838 https://doi.org/10.1007/s10571-015-0266-7

The original version of this article unfortunately contained a mistake in the unit of agmatine doses. The agmatine doses were erroneously written in nanomolar in the published article. The correct effective doses of agmatine were 150 and 250 µM.